)
Medacta Group (MOVE) investor relations material
Medacta Group Q2 2026 TU earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
H1 2026 revenue reached €368 million, up 9.7% in constant currency and 7.0% in EUR, outperforming the market across all geographies and business lines.
Major expansion projects included completion of manufacturing in Ticino, Switzerland, and land acquisition in Tennessee, US, for new capacity.
Growth was driven by innovation, surgeon education, and sales force expansion, resulting in higher volumes from new surgeons.
Strategic investments included a new automated warehouse in Italy and up to $85 million investment planned for US manufacturing.
Financial highlights
H1 2026 revenue grew 9.7% in constant currency to €368.2 million, up from €344.1 million in H1 2025.
Regional growth: EMEA 10.0% (€185M), North America 6.6% (€102M), Asia Pacific 13.1% (€73M), Latin America 16.4% (€8M).
Product line growth: Hip 8.1% (€145M), Knee 10.8% (€154M), Extremities 15.9% (€40M), Spine 4.5% (€29M).
Extremities and sports medicine segments delivered more than 2x market growth.
Outlook and guidance
FY 2026 revenue growth targeted at 10–14% in constant currency, with adjusted EBITDA margin expansion of around 50bps versus prior year (27.9%).
Mid-term (2024–2027E) revenue CAGR expected between 12–15%, with gradual adjusted EBITDA margin improvement.
H2 2026 expected to accelerate, driven by new product launches, U.S. market recovery, and India market entry.
- Achieved 18.5% revenue growth and 31% net profit increase in 2025, outpacing the market.MOVE
Investor presentation - Strong revenue and profit growth, with all segments outperforming and robust outlook guided.MOVE
H2 2025 - Revenue up 18.5% to €683.8m, led by Extremities and Knee, Parcus boosted growth, all regions strong.MOVE
Q4 2025 TU - Revenue up 19.8%, net profit up 58%, margin expansion, and Parcus Medical acquisition gain.MOVE
H1 2025 - H1 2025 revenue rose 19.8%, prompting upgraded growth and margin guidance.MOVE
H1 2025 TU - 14.3% H1 revenue growth, 30.4% net profit rise, and guidance confirmed for double-digit expansion.MOVE
H1 & CMD 2024 - 1H 2024 revenue up 14.3% to €288.6M, led by EMEA and strong Knee and Shoulder growth.MOVE
H1 2024 TU - FY 2024 revenue rose 16.2% to €590.6M, led by innovation and strong Knee and Extremities growth.MOVE
H2 2024 TU - Record 16.2% revenue growth, 53.9% net profit surge, and strong 2025 outlook.MOVE
H2 2024
Next Medacta Group earnings date
Next Medacta Group earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage